NVDA
NVIDIA Corporation
NVDA has the edge over TRT overall, supported by stronger valuation and stronger modeled upside.
TRT
Trio-Tech International
TRT trails on the overall score without a compensating advantage in the available component scores.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
TRT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
TRT's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over TRT in the historical PE scenario, which offers more potential upside but is not a forecast.
TRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $0.56 | -90% |
| Fair | 24x | $1.46 | -74% |
| Expensive | 47x | $2.81 | -50% |
| Current | 93x | $5.60 | — |
Historical ranges are pointers, not guarantees.
TRT's PE is in its expensive range at 93x.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
TRT Forward outlook
There aren't enough analyst estimates for TRT to show an outlook.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over TRT on earnings, with more consistent year-over-year improvement.
TRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.06 | +100% |
| Q2 2026 | $0.00 | +$0.01 |
| Q1 2026 | $0.04 | +$0.05 |
| Q4 2025 | -$0.01 | -117% |
| Q3 2025 | $0.03 | -50% |
| Q2 2025 | -$0.01 | -108% |
| Q1 2025 | -$0.01 | -108% |
| Q4 2024 | $0.06 | -45% |
TRT's earnings per share have fallen from their peak: $0.06 over the past year, against $0.28 in mid-2022.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over TRT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over TRT on profitability, with a higher operating margin.
TRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.9M | +29% |
| Q2 2026 | $14.9M | +40% |
| Q1 2026 | $16.5M | +124% |
| Q4 2025 | $15.6M | +82% |
| Q3 2025 | $15.5M | +58% |
| Q2 2025 | $10.7M | +9.5% |
| Q1 2025 | $7.4M | -29% |
| Q4 2024 | $8.6M | -29% |
TRT's revenue has grown year over year for six quarters in a row: $20M last quarter, up 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.3% | +6 points |
| Q2 2026 | -1.8% | -6.2 points |
| Q1 2026 | -0.5% | +4.2 points |
| Q4 2025 | 0.6% | +0.7 points |
| Q3 2025 | 0.3% | -1.1 points |
| Q2 2025 | 4.4% | +0.7 points |
| Q1 2025 | -4.7% | -5.2 points |
| Q4 2024 | 0% | -5.6 points |
TRT's operating margin was 6.3% last quarter, up 6 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over TRT on cash generation, producing positive trailing cash flow while its opponent burns cash.
TRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.1M | -567% |
| Q2 2026 | $244K | +$1.5M |
| Q1 2026 | $707K | +13% |
| Q4 2025 | -$152K | -108% |
| Q3 2025 | $887K | +$2.8M |
| Q2 2025 | -$1.2M | -$932K |
| Q1 2025 | $623K | -48% |
| Q2 2024 | -$289K | -123% |
TRT's free cash flow was −$3M over the past year, against $2M the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over TRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
TRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +27% | +2.4M shares |
| 1 year | +31% | +2.7M shares |
| 3 years | +33% | +2.8M shares |
| 5 years | +42% | +3.4M shares |
TRT has 11M diluted shares, up 31% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $63,000 |
| Q2 2026 | — |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
TRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.9x | Net Cash |
| Q2 2026 | -10.1x | Net Cash |
| Q1 2026 | -4.5x | Net Cash |
| Q4 2025 | -4.6x | Net Cash |
| Q3 2025 | -4.3x | Net Cash |
| Q2 2025 | -3.4x | Net Cash |
| Q1 2025 | -3.5x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
TRT has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
TRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.4 | Neutral |
| Stochastic | 7.5 | Oversold |
TRT's weekly RSI is 41 (neutral) and its Stochastic is 8 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over TRT on valuation relative to its sector.
TRT PE vs Technology Sector
| Metric | TRT | Sector median | Relative |
|---|---|---|---|
| PE | 93x | 28x | 235% above |
| PE % | 88 | 35 | 53 pts above |
TRT is trading at 93x earnings, a 235% premium to the Technology sector's median of 28x.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
TRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.40 | 3.7% above |
| 20 week MA | $8.43 | 34% below |
| 50 week MA | $8.47 | 34% below |
| 100 week MA | $5.72 | 2.1% below |
| 200 week MA | $4.29 | 31% above |
TRT has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over TRT on returns for 2026, with the stronger performance.
TRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.11 | $1.96 | -7.1% |
| 2021 | $1.96 | $6.27 | +220% |
| 2022 | $6.27 | $2.29 | -63% |
| 2023 | $2.29 | $2.54 | +11% |
| 2024 | $2.54 | $2.96 | +17% |
| 2025 | $2.96 | $7.00 | +136% |
| 2026 YTD | $7.00 | $5.60 | -20% |
TRT's yearly returns have swung widely, from +220% in 2021 to −63% in 2022. It's down 20% so far in 2026.